Khurram Jamil, Chief Medical Officer: Galectin Therapeutics GALT Sell · Filed 06/25

Trade details

Type: Insider sale
Amount: $23,728.98
Shares · price: 7,557 sh · $3.14 a share
Held after: 0 sh
Stock: Galectin Therapeutics GALT
Person: Khurram JamilChief Medical Officer
Trade date: 26/06/23
Filed: 26/06/25
Days to filing: 2 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 05/24~07/23

Khurram Jamil's recent trades

Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$239.2K
47,467 sh
$239.2K
Filed 06/30
Traded 06/29
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$12.7K
2,533 sh
$12.7K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$10.2K
2,037 sh
$10.2K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$341.4K
68,287 sh
$341.4K
Filed 06/26
Traded 06/26
Khurram JamilChief Medical Officer
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$25.5K
8,125 sh
$25.5K
Filed 06/23
Traded 06/23